EKS-MUM-00398
Eukaryotic Protein Kinase & Protein Phosphatase Database
TagContent
EKPD IDEKS-MUM-00398
Classification
Group/FamilyScoreE-ValueStartEndDomain Length
TK/Src448.11.9E-134269518250
StatusReviewed
Ensembl ProteinENSMUSP00000029175
UniProt AccessionP05480; Q2M4I4;
Protein NameNeuronal proto-oncogene tyrosine-protein kinase Src
Protein Synonyms/Alias Proto-oncogene c-Src; pp60c-src; p60-Src;
Gene NameSrc
Gene Synonyms/Alias Src;
Ensembl Information
Ensembl Gene IDEnsembl Protein IDEnsembl Transcript ID
ENSMUSG00000027646ENSMUSP00000090237ENSMUST00000092576
ENSMUSG00000027646ENSMUSP00000105157ENSMUST00000109531
ENSMUSG00000027646ENSMUSP00000105155ENSMUST00000109529
ENSMUSG00000027646ENSMUSP00000105159ENSMUST00000109533
ENSMUSG00000027646ENSMUSP00000029175ENSMUST00000029175
OrganismMus musculus
Functional DescriptionNon-receptor protein tyrosine kinase which is activatedfollowing engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein- coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin- 43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1. Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors. Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated calcium-activated chloride channel activation. Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr- 1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of ADRBK1, leading to beta- arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor. Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus. Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances DDX58/RIG-I-elicited antiviral signaling.Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376' (By similarity).
Protein Length535
Protein Sequence
(FASTA)
MGSNKSKPKD ASQRRRSLEP SENVHGAGGA FPASQTPSKP ASADGHRGPS AAFVPPAAEP 60
KLFGGFNSSD TVTSPQRAGP LAGGVTTFVA LYDYESRTET DLSFKKGERL QIVNNTEGDW 120
WLAHSLSTGQ TGYIPSNYVA PSDSIQAEEW YFGKITRRES ERLLLNAENP RGTFLVRESE 180
TTKGAYCLSV SDFDNAKGLN VKHYKIRKLD SGGFYITSRT QFNSLQQLVA YYSKHADGLC 240
HRLTTVCPTS KPQTQGLAKD AWEIPRESLR LEVKLGQGCF GEVWMGTWNG TTRVAIKTLK 300
PGTMSPEAFL QEAQVMKKLR HEKLVQLYAV VSEEPIYIVT EYMNKGSLLD FLKGETGKYL 360
RLPQLVDMSA QIASGMAYVE RMNYVHRDLR AANILVGENL VCKVADFGLA RLIEDNEYTA 420
RQGAKFPIKW TAPEAALYGR FTIKSDVWSF GILLTELTTK GRVPYPGMVN REVLDQVERG 480
YRMPCPPECP ESLHDLMCQC WRKEPEERPT FEYLQAFLED YFTSTEPQYQ PGENL 535
Nucleotide Sequence
(FASTA)
ATGGGCAGCA ACAAGAGCAA GCCCAAGGAC GCCAGCCAGC GGCGCCGCAG CCTGGAGCCC 60
TCGGAAAACG TGCACGGGGC AGGGGGCGCC TTCCCGGCCT CACAGACACC GAGCAAGCCC 120
GCCTCCGCCG ACGGCCACCG CGGGCCCAGC GCCGCCTTCG TGCCGCCCGC GGCCGAGCCC 180
AAGCTCTTCG GAGGCTTCAA CTCCTCGGAC ACCGTCACCT CCCCGCAGAG GGCGGGGCCT 240
CTGGCAGGTG GGGTGACCAC CTTTGTGGCC CTCTATGACT ATGAGTCACG GACAGAGACT 300
GACCTGTCCT TCAAGAAAGG GGAGCGGCTG CAGATTGTCA ATAACACAGA GGGAGACTGG 360
TGGCTGGCAC ACTCGCTGAG CACGGGACAG ACCGGTTACA TCCCCAGCAA CTATGTGGCG 420
CCCTCCGACT CCATCCAGGC TGAGGAGTGG TACTTTGGCA AGATCACTAG ACGGGAATCA 480
GAGCGGCTGC TGCTCAACGC CGAGAACCCG AGAGGGACCT TCCTCGTGAG GGAGAGTGAG 540
ACCACAAAAG GTGCCTACTG CCTCTCTGTA TCCGACTTCG ACAATGCCAA GGGCCTAAAT 600
GTGAAACACT ACAAGATCCG CAAGCTGGAC AGCGGCGGTT TCTACATCAC CTCCCGCACC 660
CAGTTCAACA GCCTGCAGCA GCTCGTGGCT TACTACTCCA AACATGCTGA TGGCCTGTGT 720
CACCGCCTCA CTACCGTATG TCCCACATCC AAGCCTCAGA CCCAGGGATT GGCCAAGGAT 780
GCGTGGGAGA TCCCCCGGGA GTCCCTGCGG CTGGAGGTCA AGCTGGGCCA GGGTTGCTTC 840
GGAGAGGTGT GGATGGGGAC CTGGAACGGC ACCACGAGGG TTGCCATCAA AACTCTGAAG 900
CCAGGCACCA TGTCCCCAGA GGCCTTCCTG CAGGAGGCCC AAGTCATGAA GAAACTGAGG 960
CACGAGAAAC TGGTGCAGCT GTATGCTGTG GTGTCGGAAG AACCCATTTA CATTGTGACA 1020
GAGTACATGA ACAAGGGGAG TCTGCTGGAC TTTCTCAAGG GGGAAACGGG CAAATATTTG 1080
CGGCTACCCC AGCTGGTGGA CATGTCTGCT CAGATCGCTT CAGGCATGGC CTATGTGGAG 1140
CGGATGAACT ATGTGCACCG GGACCTTCGA GCCGCCAATA TCCTAGTAGG GGAGAACCTG 1200
GTGTGCAAAG TGGCCGACTT TGGGTTGGCC CGGCTCATAG AAGACAACGA ATACACAGCC 1260
CGGCAAGGTG CCAAATTCCC CATCAAGTGG ACCGCCCCTG AAGCTGCTCT GTACGGCAGG 1320
TTCACCATCA AGTCGGATGT GTGGTCCTTT GGGATTCTGC TGACCGAGCT CACCACTAAG 1380
GGAAGAGTGC CCTATCCTGG GATGGTGAAC CGTGAGGTTC TGGACCAGGT GGAGCGGGGC 1440
TACCGGATGC CTTGTCCCCC CGAGTGCCCC GAGTCCCTGC ATGACCTTAT GTGCCAGTGC 1500
TGGCGGAAGG AGCCCGAGGA GCGGCCCACC TTCGAGTACC TGCAGGCCTT CCTGGAAGAC 1560
TACTTTACGT CCACTGAGCC ACAGTACCAG CCCGGGGAGA ACCTATAG 1608
Domain Profile
S: 1     lklvkklGeGqfGevwlgkwkgsvkvavktlkegtlspeafleeaqilkklrheklvkly  60
         l+l+ klG+G+fGevw+g+w+g+++va+ktlk+gt+speafl+eaq++kklrheklv+ly
Q: 269   LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY  328
         68999*******************************************************
S: 61    avvseeePiyivtelmakGslldflkeeegkklklpklvdlaaqvaeGmayleeknlihr  120
         avvse ePiyivte+m+kGslldflk e+gk+l+lp+lvd++aq+a+Gmay+e++n++hr
Q: 329   AVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHR  387
         ****9.******************************************************
S: 121   dlaarnvlvgeslvvkvadfGlarlieddeytakegaklPikWtaPeaiklgkftiksdv  180
         dl+a+n+lvge+lv+kvadfGlarlied+eyta++gak+PikWtaPea+ +g+ftiksdv
Q: 388   DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV  447
         ************************************************************
S: 181   WsfGillteivtkGkvPypGmtneevleqvergyrlprpeecpeelyelllecwkkdpee  240
         WsfGillte++tkG+vPypGm n+evl+qvergyr+p+p ecpe+l++l+++cw+k+pee
Q: 448   WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE  507
         ************************************************************
S: 241   rPtfetlqevl  251
         rPtfe+lq++l
Q: 508   RPTFEYLQAFL  518
         *******9876
Domain Sequence
(FASTA)
LRLEVKLGQG CFGEVWMGTW NGTTRVAIKT LKPGTMSPEA FLQEAQVMKK LRHEKLVQLY 60
AVVSEEPIYI VTEYMNKGSL LDFLKGETGK YLRLPQLVDM SAQIASGMAY VERMNYVHRD 120
LRAANILVGE NLVCKVADFG LARLIEDNEY TARQGAKFPI KWTAPEAALY GRFTIKSDVW 180
SFGILLTELT TKGRVPYPGM VNREVLDQVE RGYRMPCPPE CPESLHDLMC QCWRKEPEER 240
PTFEYLQAFL 250
KeywordATP-binding; Cell adhesion; Cell cycle; Cell membrane; Complete proteome; Cytoplasm; Cytoskeleton; Immunity; Kinase; Lipoprotein; Membrane; Mitochondrion; Mitochondrion inner membrane; Myristate; Nucleotide-binding; Nucleus; Phosphoprotein; Proto-oncogene; Reference proteome; S-nitrosylation; SH2 domain; SH3 domain; Transferase; Tyrosine-protein kinase; Ubl conjugation.
Sequence SourceEnsembl
Orthology
Ortholog group
Ailuropoda melanoleuca"; ?>Anolis carolinensis"; ?>Bos taurus"; ?>Callithrix jacchus"; ?>Canis familiaris"; ?>Cavia porcellus"; ?>Ciona intestinalis"; ?>Ciona savignyi"; ?>Danio rerio"; ?>Dipodomys ordii"; ?>Equus caballus"; ?>Felis catus"; ?>Gallus gallus"; ?>Gasterosteus aculeatus"; ?>Gorilla gorilla"; ?>Homo sapiens"; ?>Ictidomys tridecemlineatus"; ?>Latimeria chalumnae"; ?>Loxodonta africana"; ?>Macaca mulatta"; ?>Meleagris gallopavo"; ?>Microcebus murinus"; ?>Monodelphis domestica"; ?>Mustela putorius furo"; ?>Myotis lucifugus"; ?>Nomascus leucogenys"; ?>Oreochromis niloticus"; ?>Oryctolagus cuniculus"; ?>Oryzias latipes"; ?>Otolemur garnettii"; ?>Pan troglodytes"; ?>Pelodiscus sinensis"; ?>Pongo abelii"; ?>Rattus norvegicus"; ?>Sarcophilus harrisii"; ?>Sus scrofa"; ?>Taeniopygia guttata"; ?>Takifugu rubripes"; ?>Tetraodon nigroviridis"; ?>Xenopus tropicalis"; ?>Xiphophorus maculatus"; ?>
EKS-AIM-00340
EKS-ANC-00356
EKS-BOT-00366
EKS-CAJ-00371
EKS-CAF-00367
EKS-CAP-00399
EKS-CII-00206
EKS-CIS-00121
EKS-DAR-00747
EKS-DIO-00054
EKS-EQC-00357
EKS-FEC-00354
EKS-GAG-00310
EKS-GAA-00450
EKS-GOG-00366
EKS-HOS-00372
EKS-ICT-00347
EKS-LAC-00383
EKS-LOA-00375
EKS-MAM-00366
EKS-MEG-00302
EKS-MIM-00048
EKS-MOD-00355
EKS-MUP-00360
EKS-MYL-00367
EKS-NOL-00334
EKS-ORN-00475
EKS-ORC-00344
EKS-ORL-00435
EKS-OTG-00369
EKS-PAT-00346
EKS-PES-00326
EKS-POA-00356
EKS-RAN-00380
EKS-SAH-00337
EKS-SUS-00323
EKS-TAG-00439
EKS-TAR-00470
EKS-TEN-00465
EKS-XET-00482
EKS-XIM-00463
Gene Ontology
GO:0005856; C:cytoskeleton
GO:0005829; C:cytosol
GO:0005743; C:mitochondrial inner membrane
GO:0005634; C:nucleus
GO:0005886; C:plasma membrane
GO:0005524; F:ATP binding
GO:0020037; F:heme binding
GO:0004715; F:non-membrane spanning protein tyrosine kinase activity
GO:0004713; F:protein tyrosine kinase activity
GO:0045453; P:bone resorption
GO:0060444; P:branching involved in mammary gland duct morphogenesis
GO:0007155; P:cell adhesion
GO:0007049; P:cell cycle
GO:0016477; P:cell migration
GO:0030900; P:forebrain development
GO:0048477; P:oogenesis
GO:0018108; P:peptidyl-tyrosine phosphorylation
GO:0090263; P:positive regulation of canonical Wnt receptor signaling pathway
GO:0070374; P:positive regulation of ERK1 and ERK2 cascade
GO:0071803; P:positive regulation of podosome assembly
GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway
GO:0060065; P:uterus development
KEGG
mmu:20779;
InterPros
IPR011009; Kinase-like_dom.
IPR000719; Prot_kinase_cat_dom.
IPR017441; Protein_kinase_ATP_BS.
IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
IPR000980; SH2.
IPR001452; SH3_domain.
IPR008266; Tyr_kinase_AS.
IPR020635; Tyr_kinase_cat_dom.
Pfam
PF07714; Pkinase_Tyr; 1.
PF00017; SH2; 1.
PF00018; SH3_1; 1.
SMARTs
SM00252; SH2; 1.
SM00326; SH3; 1.
SM00219; TyrKc; 1.
Prosites
PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00109; PROTEIN_KINASE_TYR; 1.
PS50001; SH2; 1.
PS50002; SH3; 1.
Prints
PR00401; SH2DOMAIN.
PR00452; SH3DOMAIN.
PR00109; TYRKINASE.
Created Date20-Feb-2013